AstraZeneca's diabetes drug curbs heart failure, kidney risks
The biggest clinical trial so far to assess a new class of diabetes pills shows that AstraZeneca's Farxiga can prevent heart failure and cut the risk of kidney problems in a broad range of patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Cardiology | Clinical Trials | Diabetes | Endocrinology | Health | Heart | Heart Failure | Urology & Nephrology